Supplemental Table1:
Patients
Gender
(M/F)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
M
M
F
F
F
M
M
F
M
M
M
F
F
M
M
F
M
M
F
M
M
F
M
F
F
F
Clinical characteristics of patients with epilepsy.
Age
(year)
21
15
22
17
30
26
15
16
22
14
18
20
17
25
26
18
19
18
31
30
23
32
22
24
29
27
Course
(year)
15
4
3
16
24
2
2
15
16
7
4
13
5
2
14
16
4
8
2
10
5
7
4
20
16
5
AEDs before surgery
CBZ,VPA,TPM
CBZ,PHT,VPA
CBZ,VPA,TPM
CBZ,PB,LTG
VPA,CBZ,CZP
CBZ,VPA,PHT
PHT,VPA,OXC
PB,CBZ,TPM,LTG
CBZ,VPA,TPM
TPM,OXC,VPA
PHT,CBZ,CZP
VPA,TPM,LTG,PHT
VPA,TPM,CBZ
CBZ,VPA,LTG
PB,VPA,CBZ,TPM
VPA,CBZ,PB
CBZ,VPA,TPM,LTG
CBZ,VPA,TPM
CBZ,VPA,CZP
CBZ,VPA,TPM,LTG
PB,CBZ,PHT,VPA
VPA,PHT,CBZ
CBZ,PHT,TPM,OXC
CBZ,PHT,PB
PHT,PB,CBZ,VPA
CBZ,TPM,VPA
Resection
tissue
Pathology
TNl
TNr
TNr
TNl
TNl
TNl
TNr
TNl
TNl
TNl
TNr
TNl
TNr
TNr
TNr
TNr
TNl
TNl
TNl
TNr
TNr
TNl
TNr
TNl
TNl
TNr
NL,G
NL,G
NL,G
NL,G
NL
G
G
NL,G
NL,G
NL,G
NL,G
NL,G
NL,G
G
NL
NL,G
NL,G
NL,G
G
NL,G
NL,G
NL,G
NL,G
NL,G
NL,G
G
F, female; M, male; AEDs, antiepileptic drugs; CBZ, carbamazepine; VPA, valproate; PB, Phenobarbital; TPM,
topiramate; PHT, phenytoin; LTG, lamotrigine; OXC, oxcarbazepine; CZP, clonazepam; TN, temporal neocortex; l,
left; r, right; NL, neuron loss; G, Gliosis.
Supplemental Table2: Clinical characteristics of control group.
Gender
(M/F)
F
F
M
M
M
M
Age
(year)
22
31
28
16
24
18
Etiology
diagnosis
Trauma
Trauma
Trauma
Trauma
Trauma
Trauma
Resection tissue
TNr
TNl
TNl
TNr
TNl
TNr
Tissue pathology
N
N
N
N
N
N
F
F
M
F
M
F
17
26
32
23
20
19
Trauma
Trauma
Trauma
Trauma
Trauma
Trauma
F, female; M, male; TN, temporal neocortex; l, left; r, right; N, normal.
TNr
TNl
TNl
TNr
TNr
TNl
N
N
N
N
N
N